PLAC1 affects cell to cell communication by interacting with the desmosome complex.
Cancer
Desmoglein-2
Placenta
ZP-N domain
Journal
Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
17
12
2020
accepted:
01
06
2021
pubmed:
13
6
2021
medline:
28
1
2022
entrez:
12
6
2021
Statut:
ppublish
Résumé
X-linked PLAC1 is highly expressed in placenta during embryogenesis, and when ablated in mice, causes aberrant placental cell layer organization. It is also highly expressed in many types of cancer cell-lines. Although it has been shown that it promotes AKT phosphorylation in cancer cells, the exact mechanism by which it influences placental layer differentiation is unclear. To investigate the mechanism of action of PLAC1 we did cell fractionation and immunoprecipitation of the protein and Mass Spectrometry analysis to identify its interaction partners. The associated proteins were directly tested for interactions by co-transfection with PLAC1 and immunoprecipitation. Mutations in the ZP-N domain of PLAC1 were introduced to assess its involvement in the interactions. We provide evidence that Desmoglein-2 (DSG2), a component of the membrane-associated desmosomal complex, directly interacts with PLAC1. Mutations of cysteines in ZP-N domain disrupt the interaction between PLAC1 and DSG-2. Because desmosomes are responsible for establishing lateral cell-cell junctions, we suggest that direct interaction with the lateral junction protein complex may be implicated in the PLAC1 effects on cell-cell interactions, and thereby on the layer structure of the placenta.
Identifiants
pubmed: 34118612
pii: S0143-4004(21)00166-1
doi: 10.1016/j.placenta.2021.06.001
pmc: PMC8237484
mid: NIHMS1711486
pii:
doi:
Substances chimiques
PLAC1 protein, human
0
Pregnancy Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-45Subventions
Organisme : Intramural NIH HHS
ID : ZIA AG000646
Pays : United States
Informations de copyright
Published by Elsevier Ltd.
Références
Oncotarget. 2020 May 19;11(20):1862-1875
pubmed: 32499871
Nature. 2008 Dec 4;456(7222):653-7
pubmed: 19052627
Cancer Immun. 2007 Nov 06;7:18
pubmed: 17983203
Eur J Cell Biol. 2002 Nov;81(11):592-8
pubmed: 12494996
Nat Med. 2011 Jan;17(1):96-104
pubmed: 21151137
FASEB J. 2017 Aug;31(8):3412-3424
pubmed: 28438789
Mol Reprod Dev. 2005 Jul;71(3):299-304
pubmed: 15803460
Birth Defects Res A Clin Mol Teratol. 2013 Sep;97(9):571-7
pubmed: 24014101
Cancer Res. 2007 Oct 1;67(19):9528-34
pubmed: 17909063
Placenta. 2011 Nov;32(11):877-84
pubmed: 21937108
Genomics. 2000 Sep 15;68(3):305-12
pubmed: 10995572
Cell Tissue Res. 2018 Nov;374(2):317-327
pubmed: 29938327
Int J Cancer. 2008 May 1;122(9):2038-43
pubmed: 18183594
Mol Reprod Dev. 2012 Aug;79(8):564-72
pubmed: 22729990
Genome Res. 2002 Dec;12(12):1999-2003
pubmed: 12466305
J Morphol. 2006 Jan;267(1):103-8
pubmed: 16258945
BMC Biochem. 2006 Apr 06;7:11
pubmed: 16600035
Biol Reprod. 2016 Jan;94(1):6
pubmed: 26586843
Oncogenesis. 2013 Sep 02;2:e67
pubmed: 23999628